Joel Greenblatt’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$498K Sell
18,861
-171
-0.9% -$4.47K ﹤0.01% 1586
2026
Q2
$499K Buy
+19,032
New +$443K ﹤0.01% 1514

Other funds holding ARQT

Joel Greenblatt's ARQT Position: Q3 2026 in Review

Joel Greenblatt reduced its Arcutis Biotherapeutics (ARQT) stake by 0.9% in Q3 2026, selling an estimated $4.47K and leaving 18,861 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

Joel Greenblatt first reported a position in ARQT in Q2 2026 and has held it in 2 quarters since. The position peaked at $499K in Q2 2026. 294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • Joel Greenblatt held 18,861 shares of Arcutis Biotherapeutics worth $498K as of Q3 2026.
  • Joel Greenblatt sold 171 Arcutis Biotherapeutics shares in Q3 2026, an estimated $4.47K.
  • Arcutis Biotherapeutics made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1586 holding.
  • Joel Greenblatt first reported a position in Arcutis Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • Joel Greenblatt's Arcutis Biotherapeutics position peaked at $499K in Q2 2026.
  • 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.